Profile
Julien E Capers currently works at Vera Therapeutics, Inc., as Vice President & Head-Legal from 2022.
Mr. Capers also formerly worked at CareDx, Inc., as Corporate Counsel, Establishment Labs Holdings, Inc., as Associate General Counsel, and Zogenix, Inc., as Assistant General Counsel.
Mr. Capers received his undergraduate degree from Stanford University and graduate degree from UC Davis School of Law.
Julien Capers active positions
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | General Counsel | 2022-08-31 |
Former positions of Julien Capers
| Companies | Position | End |
|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | Corporate Officer/Principal | - |
| CAREDX, INC. | Corporate Officer/Principal | - |
| ZOGENIX, INC. | Corporate Officer/Principal | - |
Training of Julien Capers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UC Davis School of Law
UC Davis School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Establishment Labs Holdings, Inc.
Establishment Labs Holdings, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures medical products | Health Technology |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Julien Capers
















